# MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis Patients

> **NCT01959165** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 44 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** MEDI7183 low dose
- **DRUG:** MEDI7183 medium dose
- **DRUG:** MEDI7183 high dose
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT01959165
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11-21
- **Primary completion:** 2015-08-11
- **Final completion:** 2018-04-10
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2019-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01959165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01959165, "MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01959165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*